Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital, Inc. reported third-quarter 2026 total investment income of $140.1 million and net investment income of $87.3 million, or $0.47 per share. For the nine months ended September 30, 2026, total investment income was $430.8 million, up 9.0% year over year, and net investment income was $268.4 million, up 5.4%. The third-quarter cash distribution is $0.47 per share, comprising a $0.40 base distribution and a $0.07 supplemental distribution; November 10, 2026 is the record date and payment is scheduled for November 17, 2026.
During Q3, Hercules sold 2.3 million common shares through its equity ATM program for $39.2 million in net proceeds. Available liquidity was $506.6 million as of September 30, 2026, subject to existing terms and covenants. On October 8, 2026, Hercules issued $400.0 million of 6.700% unsecured notes due October 8, 2029. As of October 26, 2026, $571.7 million in pending commitments consisted of signed non-binding term sheets, subject to due diligence, final investment committee approval and definitive documentation. The debt investment portfolio increased $252.9 million at cost during Q3.
Hercules Capital, Inc. (HCXY) reported total investment income of $140.1 million for the three months ended September 30, 2026, compared with $138.1 million a year earlier. Net investment income was $87.3 million, versus $88.6 million, while the increase in net assets resulting from operations was $93.6 million, compared with $119.7 million.
For the nine months ended September 30, 2026, net investment income was $268.4 million versus $254.7 million, and the increase in net assets resulting from operations was $266.3 million versus $248.9 million. Net cash used in operating activities was $98.4 million, compared with $370.2 million. As of September 30, 2026, total assets were $4.95 billion, including investments at fair value of $4.85 billion; debt was $2.55 billion, net assets were $2.32 billion and net asset value was $12.26 per share, versus $12.13 at December 31, 2025. The investment schedule lists debt investments across application software, healthcare, drug development, defense technologies and other sectors.
Hercules Capital, Inc. (HCXY) President Seth H. Meyer reported two dispositions of common stock on October 9, 2026: 3,011 shares and 3,458 shares, each reported at $16.51 per share. In total, 6,469 shares were withheld to pay taxes applicable to the vesting of restricted stock.
Hercules Capital, Inc. reported that its Chief Executive Officer, Scott Bluestein, had 9,741 and 10,652 shares of common stock withheld on October 9, 2026, to pay taxes applicable to restricted-stock vesting. Each transaction lists a price of $16.51 per share.
Hercules Capital, Inc. (HCXY) Chief Legal Officer & CCO Kiersten Zaza Botelho had 1,018 and 956 common shares withheld on October 9, 2026, for a total of 1,974 shares. Each entry lists $16.51 per share. The shares were withheld to pay taxes applicable to restricted-stock vesting.
Hercules Capital, Inc. Chief Operating Officer Christian Follmann reported 1,365 and 1,433 common shares withheld to pay taxes applicable to restricted-stock vesting on October 9, 2026. Each entry lists a price of $16.51 per share. The report also lists 350 common shares held indirectly by his spouse.
On October 8, 2026, Hercules Capital, Inc. (HCXY) closed an offering of $400,000,000 in aggregate principal amount of its 6.700% notes due October 8, 2029. The notes pay interest at 6.700% per year semiannually in arrears on April 8 and October 8, beginning April 8, 2027. Hercules expects to use net proceeds to repay outstanding unsecured and/or secured indebtedness under its financing arrangements, fund investments in accordance with its investment objectives, and for other general corporate purposes.
The notes are unsecured and are not guaranteed by subsidiaries. They rank equally with liabilities that are not subordinated, ahead of debt expressly subordinated to them, behind secured indebtedness to the extent of collateral value, and structurally behind indebtedness of subsidiaries, financing vehicles and similar facilities. Hercules may redeem the notes at par plus a make whole premium, if applicable. The indenture includes covenants on specified asset-coverage provisions and providing financial information if Hercules ceases to have Exchange Act reporting requirements, subject to limitations and exceptions.
Hercules Capital, Inc. (symbol: HCXY) is the issuer of record for a Form 4 filing submitted to the SEC. Fichera Alfred reported acquisition or exercise transactions in this Form 4 filing.
Hercules Capital, Inc. (HCXY) director Alfred Fichera received an automatic grant of 3,483 shares of restricted common stock on September 17, 2026, valued at $17.76 per share. All 3,483 shares are held directly and are subject to time-based vesting and forfeiture conditions.
The award was granted under the 2026 Non-Employee Director Plan. The shares vest in three equal installments of 1,161 shares on August 15, 2027, July 11, 2028, and June 18, 2029, if service conditions are met.
Hercules Capital, Inc. (HCXY) reported that director Alfred Fichera currently holds no shares of the company’s Common Stock. A Form 3 filing dated September 17, 2026 lists a direct ownership position of 0 shares of Common Stock following the reported holdings entry.
Hercules Capital, Inc. reported that its Board of Directors increased in size from seven to eight members and elected Alfred B. Fichera, age 67, as an independent Class I director, effective September 17, 2026, with a term expiring in 2029. The Board and its committees determined he is independent under New York Stock Exchange standards and not an “interested person” under Section 2(a)(19) of the Investment Company Act of 1940. He will receive the standard cash and equity compensation for non-employee directors and has entered into an indemnification agreement with the company.
Fichera will serve on the Audit Committee. He worked at KPMG LLP from 1982 until 2019, including as Global Head of Alternative Investments and as an audit partner for nearly 25 years, and since 2021 has served as an expert witness on valuation, board governance and SEC filings. Since September 2025, he has been an independent director and audit committee chair of Warburg Pincus Access Fund, L.P. Hercules highlighted in its press release that, since inception in December 2003, it has committed more than $28 billion to over 700 companies and that its common stock trades under “HTGC,” with a 6.25% Notes due 2033 issuance trading under “HCXY.”